![](https://www.anaphylaxis.org.uk/wp-content/uploads/2025/02/pexels-kampus-5940831-scaled.jpg?x26440)
The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to help students learn directly from patients about their
Read more![](https://www.anaphylaxis.org.uk/wp-content/uploads/2025/02/pexels-karolina-grabowska-7195086-scaled.jpg?x26440)
The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax is the first therapy specifically designed to treat
Read more![](https://www.anaphylaxis.org.uk/wp-content/uploads/2025/02/pexels-jsa2021-4299436-scaled.jpg?x26440)
ARS Pharmaceuticals has made significant progress in expanding access to neffy®, its needle-free adrenaline (epinephrine) nasal spray. After gaining approval in the U.S. and Europe for treating severe allergic reactions like anaphylaxis, ARS Pharmaceuticals has now filed for approval in
Read more![](https://www.anaphylaxis.org.uk/wp-content/uploads/2025/02/pexels-anna-nekrashevich-6801648-scaled.jpg?x26440)
A recent announcement from DBV Technologies revealed promising long-term results from its EPITOPE Study. Results from a 3-year study showed that the VIASKIN® Peanut patch can help children with peanut allergies become less sensitive to peanuts, reducing the risk of
Read more![](https://www.anaphylaxis.org.uk/wp-content/uploads/2025/02/pexels-gustavo-fring-3985062-scaled.jpg?x26440)
A group of health care professionals and patient representatives have created a Task Force on Food Allergen Ingestion Risk (‘FAIR’) within the European Academy of Allergy and Clinical Immunology (EAACI). This team is working to explore the challenges and needs
Read more![](https://www.anaphylaxis.org.uk/wp-content/themes/anaphylaxis/assets/images/placeholder.png?x26440)
As we look ahead and finalise our plans for 2025, we wanted to take a moment to reflect on some of our highlights from the year that was 2024. From new resources and awareness campaigns to new initiatives and development of our AllergyWise® training programme, we were proud to be able to recognise our 30th anniversary with so many positive strides towards creating a brighter future for those living with serious allergies.
Read more![](https://www.anaphylaxis.org.uk/wp-content/uploads/2025/01/pexels-viridianaor-19797276-scaled.jpg?x26440)
Living with allergies can sometimes feel isolating, especially when it seems like no one fully understands your struggles or when progress toward better solutions feels slow. However, it’s essential to look toward research to see the great strides being made
Read more![](https://www.anaphylaxis.org.uk/wp-content/uploads/2025/01/pexels-goumbik-669610-scaled.jpg?x26440)
A recent study published in Clinical and Experimental Allergy looked at how food allergies have changed over time by comparing two groups of children from the Isle of Wight—one born in 1989-1990 and the other in 2001-2002. This study explores
Read more![](https://www.anaphylaxis.org.uk/wp-content/uploads/2025/01/man-2557408_1280.jpg?x26440)
Valentine’s Day is about enjoying each other’s company, and with a little planning and communication, you can make sure it’s both safe and special. Happy Valentine’s Day!
Read more